Dr Bo Soo Kim, MD in Baltimore, MD - Medicare Pulmonary Disease

Dr Bo Soo Kim, MD is a medicare enrolled "Internal Medicine - Pulmonary Disease" physician in Baltimore, Maryland. He went to Jefferson Medical College Of Thomas Jefferson University and graduated in 2002 and has 22 years of diverse experience with area of expertise as Pulmonary Disease. He is a member of the group practice Johns Hopkins University and his current practice location is 5501 Hopkins Bayview Cir, Rm 4b74, Baltimore, Maryland. You can reach out to his office (for appointments etc.) via phone at (410) 550-0545.

Dr Bo Soo Kim is licensed to practice in Maryland (license number D72738) and he also participates in the medicare program. He accepts medicare assignments (which means he accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance) and his NPI Number is 1649294695.

Contact Information

	Dr Bo Soo Kim, MD
	5501 Hopkins Bayview Cir, Rm 4b74, Baltimore, MD 21224-6821
	(410) 550-0545
	(410) 550-2612

Physician's Profile

Full Name	Dr Bo Soo Kim
Gender	Male
Speciality	Pulmonary Disease
Experience	22 Years
Location	5501 Hopkins Bayview Cir, Baltimore, Maryland
Accepts Medicare Assignments	Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance.

Medical Education and Training:

Dr Bo Soo Kim attended and graduated from Jefferson Medical College Of Thomas Jefferson University in 2002

NPI Data:

NPI Number: 1649294695
Provider Enumeration Date: 07/26/2006
Last Update Date: 09/16/2011

Medicare PECOS Information:

PECOS PAC ID: 7416951298
Enrollment ID: I20111011000343

Medical Identifiers

Medical identifiers for Dr Bo Soo Kim such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1649294695	NPI	-	NPPES

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
207RP1001X	Internal Medicine - Pulmonary Disease	D72738 (Maryland)	Primary

Medical Facilities Affiliation

Facility Name	Location	Facility Type
Johns Hopkins Hospital, The	Baltimore, MD	Hospital

Group Practice Association

Group Practice Name	Group PECOS PAC ID	No. of Members
Johns Hopkins University	8921903147	2692

News Archive

iRGD peptide found to enhance both cancer detection and treatment

Researchers at Burnham Institute for Medical Research at University of California, Santa Barbara have identified a peptide (a chain of amino acids) that specifically recognizes and penetrates cancerous tumors but not normal tissues.

Genetic variant increases risk of lung cancer for light and heavy smokers, say researchers

Individuals with a certain type of genetic susceptibility to lung cancer face a greatly increased risk for the deadly disease with even a small exposure to cigarette smoke, a study team that includes researchers from the University of Cincinnati has concluded.

Data from Phase II clinical trial of NKTR-118 presented

Data from a phase II study demonstrated that oral NKTR-118 improved lower gastrointestinal dysfunction by increasing the frequency of bowel movements in patients with opioid-induced constipation, while simultaneously preserving opioid-mediated analgesia.

MD Anderson and Takeda announce agreement to develop off-the-shelf CAR NK-cell therapy platform

The University of Texas MD Anderson Cancer Center and Takeda Pharmaceutical Company Limited today announced an exclusive license agreement and research agreement to develop cord blood-derived chimeric antigen receptor-directed natural killer (CAR NK)-cell therapies, 'armored' with IL-15, for the treatment of B-cell malignancies and other cancers.

Laminin-111 protein therapy could treat Duchenne muscular dystrophy

A novel treatment in development at the University of Nevada School of Medicine for the most common form of muscular dystrophy is advancing towards human trials with a $308,000 boost from the Muscular Dystrophy Association.

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Medicare reassignment of benefits is a mechanism by which practitioners allow third parties to bill and receive payment for medicare services performed by them. Dr Bo Soo Kim allows following entities to bill medicare on his behalf.

Entity Name	Johns Hopkins University
Entity Type	Part B Supplier - Clinic/group Practice
Entity Identifiers	NPI Number: 1922008549 PECOS PAC ID: 8921903147 Enrollment ID: O20031215000719

News Archive

iRGD peptide found to enhance both cancer detection and treatment

Genetic variant increases risk of lung cancer for light and heavy smokers, say researchers

Data from Phase II clinical trial of NKTR-118 presented

MD Anderson and Takeda announce agreement to develop off-the-shelf CAR NK-cell therapy platform

Laminin-111 protein therapy could treat Duchenne muscular dystrophy

iRGD peptide found to enhance both cancer detection and treatment

Genetic variant increases risk of lung cancer for light and heavy smokers, say researchers

Data from Phase II clinical trial of NKTR-118 presented

MD Anderson and Takeda announce agreement to develop off-the-shelf CAR NK-cell therapy platform

Laminin-111 protein therapy could treat Duchenne muscular dystrophy

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Dr Bo Soo Kim is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Dr Bo Soo Kim, MD 5501 Hopkins Bayview Cir, Rm 4b74, Baltimore, MD 21224-6821 Ph: (410) 550-0545	Dr Bo Soo Kim, MD 5501 Hopkins Bayview Cir, Rm 4b74, Baltimore, MD 21224-6821 Ph: (410) 550-0545

News Archive

iRGD peptide found to enhance both cancer detection and treatment

Genetic variant increases risk of lung cancer for light and heavy smokers, say researchers

Data from Phase II clinical trial of NKTR-118 presented

MD Anderson and Takeda announce agreement to develop off-the-shelf CAR NK-cell therapy platform

Laminin-111 protein therapy could treat Duchenne muscular dystrophy

Internal Medicine Doctors in Baltimore, MD

Dr. Leonard Anang Sowah, M.D. Pulmonary Disease Medicare: Medicare Enrolled Practice Location: 22 S Greene St, Baltimore, MD 21201 Phone: 410-706-4619 Fax: 410-706-2062
Dr. Bhavandeep Singh Bajaj, M.D. Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 3345 Wilkens Avenue, Suite L10, Baltimore, MD 21229 Phone: 410-644-4444 Fax: 410-644-4484
Dr. Yonas Sisay, M.D. Pulmonary Disease Medicare: Not Enrolled in Medicare Practice Location: 822 Guilford Ave, #100, Baltimore, MD 21202 Phone: 410-385-9672
Dr. Stephen John Witanowski, MD Pulmonary Disease Medicare: Medicare Enrolled Practice Location: 2700 Quarry Lake Dr, Suite 280, Baltimore, MD 21209 Phone: 410-469-5544 Fax: 410-585-2867
Dr. Susrutha Kotwal, MD Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 4940 Eastern Ave, Mfl Bldg, West Tower, 6th Floor, Baltimore, MD 21224 Phone: 410-550-5018
Dr. Mitesh G Trambadia, M.D. Pulmonary Disease Medicare: Medicare Enrolled Practice Location: 6701 N Charles St Ste 5218, Baltimore, MD 21204 Phone: 443-849-3786
Ronak K Patel, M.D. Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 201 E University Pkwy, Baltimore, MD 21218 Phone: 410-554-2000

Dr Bo Soo Kim, MD - Medicare Pulmonary Disease in Baltimore, MD

Contact Information

Physician's Profile

Medical Identifiers

Medical Taxonomies and Licenses

Medical Facilities Affiliation

Group Practice Association

iRGD peptide found to enhance both cancer detection and treatment

Genetic variant increases risk of lung cancer for light and heavy smokers, say researchers

Data from Phase II clinical trial of NKTR-118 presented

MD Anderson and Takeda announce agreement to develop off-the-shelf CAR NK-cell therapy platform

Laminin-111 protein therapy could treat Duchenne muscular dystrophy

Medicare Reassignments

iRGD peptide found to enhance both cancer detection and treatment

Genetic variant increases risk of lung cancer for light and heavy smokers, say researchers

Data from Phase II clinical trial of NKTR-118 presented

MD Anderson and Takeda announce agreement to develop off-the-shelf CAR NK-cell therapy platform

Laminin-111 protein therapy could treat Duchenne muscular dystrophy

iRGD peptide found to enhance both cancer detection and treatment

Genetic variant increases risk of lung cancer for light and heavy smokers, say researchers

Data from Phase II clinical trial of NKTR-118 presented

MD Anderson and Takeda announce agreement to develop off-the-shelf CAR NK-cell therapy platform

Laminin-111 protein therapy could treat Duchenne muscular dystrophy

Medicare Part D Prescriber Enrollment

Mailing Address and Practice Location

iRGD peptide found to enhance both cancer detection and treatment

Genetic variant increases risk of lung cancer for light and heavy smokers, say researchers

Data from Phase II clinical trial of NKTR-118 presented

MD Anderson and Takeda announce agreement to develop off-the-shelf CAR NK-cell therapy platform

Laminin-111 protein therapy could treat Duchenne muscular dystrophy

Internal Medicine Doctors in Baltimore, MD